Podbit · Moonshots with Peter Diamandis
The NIH budget has ballooned to $45 billion yet drugs are more expensive than ever. Researchers spend 45% of their time on grant paperwork. The median intramural NIH scientist is 71. Kratsios argues the problem isn't money — it's that the scientific enterprise refuses to experiment on itself.
Where this was said
At 31:30 · chapter starts 31:15
The interview pivots to the substantive heart of the Golden Age Report: why, despite record budgets and better tools, is scientific productivity declining? Kratsios traces the problem to institutional inertia — a system designed decades ago that nobody wants to change, especially those who have succeeded within it. [1] — Michael Kratsios "The NIH budget has ballooned to $45 billion yet drugs are more expensive than ever. Researchers spend 45% of their time on grant paperwork.…" 31:30 The data is damning: the NIH budget has swelled to nearly $45 billion yet drugs are more expensive than ever. A National Academies study found researchers spend 45% of their time on grant administration. The median age of an intramural NIH scientist is 71 — while the average age of Nobel-winning scientific work is in a researcher's 20s. The scientific community, Kratsios observes wryly, is perhaps the community least interested in experimenting with new ways of doing science. The irony is not lost on either speaker.
Despite NIH's budget growing to nearly $45 billion, the cost of drugs is higher than ever, indicating declining returns on science spending.
A National Academies study found that researchers spend 45% of their time on administrative grant-related work rather than actual science.
Social norms compress behavior so effectively that we assume other minds are similar to ours. They almost never are. After running over 100 psychology studies, Greenberg's biggest finding is that humans are far more different from each other than we intuitively believe.
The widely shared claim that we have a credit card's worth of plastic in our brains may be a massive overestimate. Researchers used nitrile gloves to measure microplastics — and nitrile gloves shed microplastic particles onto the measuring device. A second paper found the original tool used was unreliable, and that we may have far less plastic than reported.
RSD isn't just hurt feelings — it's a dopamine-deficient brain with a hyperactive amygdala and a frayed connection to the prefrontal cortex. Add a surge of norepinephrine and you get chest pain, sweating, and trembling that convinces your body something catastrophic is happening.
In Dan Ariely's door experiment, participants sacrificed the highest-reward door — repeatedly — just to avoid seeing other doors disappear. Even when researchers trained them to use the best door, they kept wasting clicks to maintain options. This is the bias that runs our lives: we'll take a worse outcome to preserve the feeling of optionality.
Dan Gilbert discovered that the brain has a 'psychological immune system' — it misremembers, reframes, and rationalizes to keep you satisfied with whatever you chose. The fear before commitment is all about potential regret. But after committing, your brain quietly starts justifying the choice — and the more irreversible the decision, the stronger the effect.
The psychological immune system can get you through the first few months of any commitment. But durable, long-term well-being requires self-concordance — choosing commitments that are genuinely aligned with your values and what you actually want. Without that alignment, the satisfaction fades fast.
Vision didn't just help animals find food — it ignited the Cambrian explosion of speciation. Half of the human cortex is devoted to visual processing, and that same visual hierarchy directly inspired the neural network architectures powering today's AI.
Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.
A pharmaceutical is not an amino acid sequence — it is the successful solution to manufacturing, purification, formulation, and consistency challenges. When clinical trials prove a drug works, they validate a specific product under specific processes, not every preparation that shares the same sequence.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.